Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22405557 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)
Condition: Influenza
Interventions: Biological: Pandemic influenza vaccine (GSK1119711A)-formulation 1;   Biological: Pandemic influenza vaccine (GSK1119711A)-formulation 2

Study has passed its completion date and status has not been verified in more than two years.